Saxenda (liraglutide) is a prescription medication approved for weight management in adults with obesity or overweight in the context of additional weight-related conditions, such as hypertension, type 2 diabetes, or dyslipidemia. It is an injectable medicine that works by mimicking a hormone called glucagon-like peptide-1 (GLP-1) that targets areas of the brain which regulate appetite and food intake, leading to reduced hunger and calorie intake. Saxenda is typically used alongside a reduced-calorie diet and increased physical activity for chronic weight management. It is administered once daily via a pre-filled, injectable pen. As with any medication, it is important to discuss the potential benefits and risks with a healthcare provider.